Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12796022rdf:typepubmed:Citationlld:pubmed
pubmed-article:12796022lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:12796022lifeskim:mentionsumls-concept:C0494165lld:lifeskim
pubmed-article:12796022lifeskim:mentionsumls-concept:C1527249lld:lifeskim
pubmed-article:12796022lifeskim:mentionsumls-concept:C0282460lld:lifeskim
pubmed-article:12796022lifeskim:mentionsumls-concept:C0071126lld:lifeskim
pubmed-article:12796022lifeskim:mentionsumls-concept:C1883256lld:lifeskim
pubmed-article:12796022lifeskim:mentionsumls-concept:C1134564lld:lifeskim
pubmed-article:12796022lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:12796022pubmed:issue6lld:pubmed
pubmed-article:12796022pubmed:dateCreated2003-6-10lld:pubmed
pubmed-article:12796022pubmed:abstractTextA prospective phase II study was performed to determine the feasibility, efficacy and safety of arterial hepatic infusion (HAI) using pirarubicin combined with intravenous chemotherapy.lld:pubmed
pubmed-article:12796022pubmed:languageenglld:pubmed
pubmed-article:12796022pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12796022pubmed:citationSubsetIMlld:pubmed
pubmed-article:12796022pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12796022pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12796022pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12796022pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12796022pubmed:statusMEDLINElld:pubmed
pubmed-article:12796022pubmed:monthJunlld:pubmed
pubmed-article:12796022pubmed:issn0923-7534lld:pubmed
pubmed-article:12796022pubmed:authorpubmed-author:JacobJJlld:pubmed
pubmed-article:12796022pubmed:authorpubmed-author:ColinPPlld:pubmed
pubmed-article:12796022pubmed:authorpubmed-author:SeitzJ FJFlld:pubmed
pubmed-article:12796022pubmed:authorpubmed-author:BaulieuxJJlld:pubmed
pubmed-article:12796022pubmed:authorpubmed-author:RougierPPlld:pubmed
pubmed-article:12796022pubmed:authorpubmed-author:CouzigouPPlld:pubmed
pubmed-article:12796022pubmed:authorpubmed-author:MahjoubiMMlld:pubmed
pubmed-article:12796022pubmed:authorpubmed-author:AdenisAAlld:pubmed
pubmed-article:12796022pubmed:authorpubmed-author:DouillardJ...lld:pubmed
pubmed-article:12796022pubmed:authorpubmed-author:DucreuxMMlld:pubmed
pubmed-article:12796022pubmed:authorpubmed-author:YchouMMlld:pubmed
pubmed-article:12796022pubmed:authorpubmed-author:MahjoubiRRlld:pubmed
pubmed-article:12796022pubmed:authorpubmed-author:FallikDDlld:pubmed
pubmed-article:12796022pubmed:issnTypePrintlld:pubmed
pubmed-article:12796022pubmed:volume14lld:pubmed
pubmed-article:12796022pubmed:ownerNLMlld:pubmed
pubmed-article:12796022pubmed:authorsCompleteYlld:pubmed
pubmed-article:12796022pubmed:pagination856-63lld:pubmed
pubmed-article:12796022pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12796022pubmed:meshHeadingpubmed-meshheading:12796022...lld:pubmed
pubmed-article:12796022pubmed:meshHeadingpubmed-meshheading:12796022...lld:pubmed
pubmed-article:12796022pubmed:meshHeadingpubmed-meshheading:12796022...lld:pubmed
pubmed-article:12796022pubmed:meshHeadingpubmed-meshheading:12796022...lld:pubmed
pubmed-article:12796022pubmed:meshHeadingpubmed-meshheading:12796022...lld:pubmed
pubmed-article:12796022pubmed:meshHeadingpubmed-meshheading:12796022...lld:pubmed
pubmed-article:12796022pubmed:meshHeadingpubmed-meshheading:12796022...lld:pubmed
pubmed-article:12796022pubmed:meshHeadingpubmed-meshheading:12796022...lld:pubmed
pubmed-article:12796022pubmed:meshHeadingpubmed-meshheading:12796022...lld:pubmed
pubmed-article:12796022pubmed:meshHeadingpubmed-meshheading:12796022...lld:pubmed
pubmed-article:12796022pubmed:meshHeadingpubmed-meshheading:12796022...lld:pubmed
pubmed-article:12796022pubmed:meshHeadingpubmed-meshheading:12796022...lld:pubmed
pubmed-article:12796022pubmed:meshHeadingpubmed-meshheading:12796022...lld:pubmed
pubmed-article:12796022pubmed:meshHeadingpubmed-meshheading:12796022...lld:pubmed
pubmed-article:12796022pubmed:meshHeadingpubmed-meshheading:12796022...lld:pubmed
pubmed-article:12796022pubmed:meshHeadingpubmed-meshheading:12796022...lld:pubmed
pubmed-article:12796022pubmed:meshHeadingpubmed-meshheading:12796022...lld:pubmed
pubmed-article:12796022pubmed:meshHeadingpubmed-meshheading:12796022...lld:pubmed
pubmed-article:12796022pubmed:meshHeadingpubmed-meshheading:12796022...lld:pubmed
pubmed-article:12796022pubmed:meshHeadingpubmed-meshheading:12796022...lld:pubmed
pubmed-article:12796022pubmed:meshHeadingpubmed-meshheading:12796022...lld:pubmed
pubmed-article:12796022pubmed:year2003lld:pubmed
pubmed-article:12796022pubmed:articleTitleHepatic arterial infusion using pirarubicin combined with systemic chemotherapy: a phase II study in patients with nonresectable liver metastases from colorectal cancer.lld:pubmed
pubmed-article:12796022pubmed:affiliationInstitut Gustave Roussy, Villejuif, France.lld:pubmed
pubmed-article:12796022pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12796022pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:12796022pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:12796022pubmed:publicationTypeMulticenter Studylld:pubmed
pubmed-article:12796022pubmed:publicationTypeClinical Trial, Phase IIlld:pubmed